Pharsight

Mayne Pharma Intl patents expiration

1. Tolsura patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8771739 MAYNE PHARMA INTL Pharmaceutical compositions for poorly soluble drugs
Jul, 2023

(2 months ago)

US10806792 MAYNE PHARMA INTL Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US10463740 MAYNE PHARMA INTL Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US9713642 MAYNE PHARMA INTL Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US8921374 MAYNE PHARMA INTL Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

US9272046 MAYNE PHARMA INTL Itraconazole compositions and dosage forms, and methods of using the same
Jun, 2033

(9 years from now)

Drugs and Companies using ITRACONAZOLE ingredient

Market Authorisation Date: 11 December, 2018

Treatment: Treatment of fungal infections, including blastomycosis, histoplasmosis, and aspergillosis

Dosage: CAPSULE;ORAL

More Information on Dosage

TOLSURA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic